Early integration of clinical, operational, and patient-level insights during trial development can help close the gap between evidence generation and commercial performance, improving alignment between product value and real-world adoption.
Giovanni Guzzo, PhD
Advertisement
Giovanni Guzzo, PhD
Sr. Clinical Country & Site Lead
Associate Director, Global Clinical Operations
Biogen
Articles by Giovanni Guzzo, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Seeks Public Input on Early-Phase Clinical Trial Design for Ibogaine
2
FDA Releases Transparency Roadmap Outlining Disclosure Priorities Across Drug Development and Regulatory Review
3
Mixed Outsourcing Models Are Spreading. Is Sponsor Oversight Keeping Up?
4
Beyond the Molecule: Why Radiopharmaceutical Trials Require a New Operating Model
5